New immunotherapy ‘highly effective’ against hepatitis B
Genes associated with COVID-19 risk identified
14 May 2021Early biomarker warning of heart disease for diabetic patients
14 May 2021New immunotherapy ‘highly effective’ against hepatitis B
Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.
